Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Esztergom – page 90

1 116 clinical trials in Esztergom, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Esztergom at a glance
1 116
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 116 trials in Esztergom

Open in trial search

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Oesophageal carcinoma

Not recruiting

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Epoetin Alfa
  • Sponsor:Celgene Corp.

Tourette's disorder

Not recruiting

Study on the Long-Term Safety of Ecopipam Hydrochloride Tablets for Children, Adolescents, and Adults with Tourette's Disorder

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Ecopipam Hydrochloride
  • Sponsor:Emalex Biosciences Inc.

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Colitis ulcerative

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Ulcerative Colitis

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab and Lenvatinib for Patients with Advanced Non-Clear Cell Kidney Cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lenvatinib
  • Sponsor:Merck Sharp & Dohme LLC

Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rifaximin
  • Sponsor:Salix Pharmaceuticals Inc.

Study to Determine Safe Doses of Selexipag for Children with Pulmonary Arterial Hypertension

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Selexipag
  • Sponsor:Actelion Pharmaceuticals Ltd.

Study on Ampreloxetine and Midodrine Hydrochloride for Treating Neurogenic Orthostatic Hypotension in Patients with Multiple System Atrophy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ampreloxetine
  • Sponsor:Theravance Biopharma Ireland Limited

Crohn's disease

Not recruiting

Study on Ustekinumab for Children with Moderate to Severe Crohn's Disease

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Ustekinumab
  • Sponsor:Janssen - Cilag International

Study Comparing OXU-001 and Intravitreal Dexamethasone for Patients with Diabetic Macular Edema

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Oxular IE Limited

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Esztergom

What the registry says about research in the country

01 Neurology Research

Ongoing clinical research focusing on Multiple Sclerosis (MS) aims to evaluate the long-term effectiveness of innovative therapeutic approaches. These trials build upon previous research to assess treatment continuity and patient outcomes.

  • Disease Management Studies
  • Treatment Effectiveness Evaluation
  • Long-term Safety Assessment

Current investigations examine how patients previously involved in MS research respond to continued therapeutic interventions, providing valuable insights into treatment sustainability and long-term benefits.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.